Author

A. Vernet

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1 Pharmacology & Toxicology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 4 Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Akhmanova· 1 shared A. Andrieux· 1 shared A. B. Popov· 1 shared A. G. Baker· 1 shared A. Graveline· 1 shared A. Jiang· 1 shared A. R. Graveline· 1 shared A. Rai· 1 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 7 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Akhmanova

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

An Fc-SPINK1 fusion protein inhibits pancreatic inflammation in a mouse model

Jeffrey C. Way, Daniel Heid, M. Theiß, Simon Flyvbjerg Nørrelykke, Lucas Barck, L. Burger, J. A. Bredl, Thorge Dobbertin, P. Höflich, Tobias Stadelmann, Dominik Niopek, Katherine Redfield Chan, R. Sivaraman, A. R. Graveline, A. Vernet, , P. A. Silver

This paper develops an Fc-SPINK1 fusion protein that reduces pancreatic inflammation in mice by extending its half-life and inhibiting trypsin activity.

bioRxiv · Feb 21, 2025 · PreprintPharmacology & Toxicology

DNA origami vaccine (DoriVac) nanoparticles improve both humoral and cellular immune responses to infectious diseases

Y. Zeng, O. Young, Q. Xiong, L. Si, M. W. Ku, S. Bernier, H. Dembele, G. Isinelli, T. Gilboa, Z. Swank, S. H. Seok, A. Rajwar, A. Jiang, Y. Zhai, L. Williams, , W. Shih

This study demonstrates that DNA origami vaccine nanoparticles enhance both humoral and cellular immune responses against infectious diseases like SARS-CoV-2, HIV, and Ebola.

bioRxiv · Dec 29, 2023 · PreprintImmunology

In Vivo Monitoring of Cellular Senescence by Photoacoustic and Fluorescence Imaging Utilizing a Nanostructured Organic Probe

A. G. Baker, H.-L. Ou, M. Hartono, A. B. Popov, E. L. Brown, J. Joseph, M. Golinska, C. Sanghera, E. Gonzalez-Gualda, D. Macias, T. R. Else, H. F. Greer, A. Vernet, S. E. Bohndiek, L. Fruk, D. Munoz-Espin

This study develops a nanostructured organic probe, NanoJaggs, for in vivo monitoring of cellular senescence using photoacoustic and fluorescence imaging, showing specificity for chemotherapy-induced senescence in tumors.

bioRxiv · Jul 12, 2023 · PreprintCancer Biology

High-frequency synthetic apomixis in hybrid rice

A. Vernet, D. Meynard, Q. Lian, D. Mieulet, O. Gibert, M. Bissah, R. Rivallan, A.-c. Meunier, K. Shankle, J. Frouin, K. Shankle, I. Khanday, R. Mercier, V. Sundaresan, E. Guiderdoni

This study demonstrates high-frequency synthetic apomixis in hybrid rice by inducing MiMe mutations and BBM1 expression, resulting in over 95% clonal seed production across generations.

bioRxiv · Oct 14, 2022Plant Biology

Two antagonistic microtubule targeting drugs act synergistically to kill cancer cells

L. Peronne, E. Denarier, A. Rai, R. Prudent, A. Vernet, P. Suzanne, S. Ramirez-Rios, S. Michallet, M. Guidetti, J. Vollaire, D. Lucena-Agell, A.-S. Ribba, V. Josserand, J.-L. Coll, P. Dallemagne, , L. Lafanechere

The paper identifies Carba1, a microtubule-destabilizing drug, which synergizes with paclitaxel to enhance cancer cell killing in vitro and in vivo.

bioRxiv · Feb 6, 2020Cancer Biology